Clinical Trial Testing the BioSerenity Pulse Oximeter (EOXY) Efficacy, Performance and Safety in Healthy Volunteer

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

December 15, 2017

Study Completion Date

November 6, 2018

Conditions
Healthy
Interventions
DEVICE

EOXY device

Sp02 and HR measures from EOXY device are simulateously compared to gold standard measures : Sa02 sampling measures and pulse oximeter gold standard

DEVICE

Gold standard oximeter

Sp02 and HR measures from EOXY device are simulateously compared to gold standard measures : Sa02 sampling measures and pulse oximeter gold standard

PROCEDURE

SaO2 sampling

Sp02 and HR measures from EOXY device are simulateously compared to gold standard measures : Sa02 sampling measures and pulse oximeter gold standard

Trial Locations (1)

1348

Université catholique louvain la neuve, centre sportif, Louvain-la-Neuve

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

NAMSA

OTHER

collaborator

Université Catholique de Louvain

OTHER

lead

BioSerenity

INDUSTRY

NCT03614416 - Clinical Trial Testing the BioSerenity Pulse Oximeter (EOXY) Efficacy, Performance and Safety in Healthy Volunteer | Biotech Hunter | Biotech Hunter